Evidence map›Paper›PMID 11349093›Full record

ArticleInfection and immunity2001

gp96-peptide vaccination of mice against intracellular bacteria.

U Zügel, A M Sponaas, J Neckermann, B Schoel, S H Kaufmann

Abstract read
In one paragraph

Article in Infection and immunity, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. DNA immunization as an efficient strategy for vaccination.Avicenna journal of medical biotechnology · 2009
    Article
  12. Article
  13. Essential role of CD91 in re-presentation of gp96-chaperoned peptides.Proceedings of the National Academy of Sciences of the United States of America · 2004
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

U ZügelDepartment of Immunology, University of Ulm, Germany.
A M Sponaas
J Neckermann
B Schoel
S H Kaufmann
Max Planck Society · DEUniversität Ulm · DEMax Planck Institute for Infection Biology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work demonstrates that gp96 preparations isolated from cells infected with intracellular bacteria induce cytotoxic T-lymphocyte responses and confer protection. Our findings extend previous reports on the immunogenicity of gp96-associated peptides to antigens derived from intracellular bacteria. Immunization with gp96 may therefore represent a promising vaccination strategy against bacterial pathogens.

Indexed as

VaccinationAnimalsCD8-Positive T-LymphocytesHeat-Shock ProteinsListeria monocytogenesListeriosisMiceMice, Inbred C57BLMycobacterium tuberculosisPeptidesSpleenTuberculosisHeat-Shock ProteinsPeptides

Identifiers

PMID11349093
PMCPMC98486
OpenAlexW2112538651

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.